The page is the record's research on the issuer — no analyst, no rating, no view. # PLIANT THERAPEUTICS, INC. (NASDAQ: PLRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is PLIANT THERAPEUTICS, INC., listed on NASDAQ under ticker PLRX, with ISIN US7291391057 and LEI 5493002Q5LITR7VHZH02. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The listing status is listed, not halted. ## The disclosure read The record holds 56 filings in the twelve months from 2025-11-08 to 2026-11-08, across 24 filing days. The median gap between filing days is 10 days. The latest filing is dated 2026-10-02 and is of type directors_dealings, 37 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filing count is 52, and the median latency is 5.0 days. In the sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filing count is 63.0, and the median latency is 4.0 days. By type the filings are 25 directors_dealings, 15 regulatory_filing, 6 results, 4 director_change, 3 agm_egm, 2 corporate_news and 1 prospectus. ## Auditor The auditor of record is Deloitte & Touche LLP, located in San Francisco, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001746473.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/PLRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1746473/000174647326000037/plrx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/PLRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PLRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp